13F FILING · QUARTER ENDING 2026-03-31

What Renaissance Technologies owns

Jim Simons' firm reported $63.93B across 3213 US stock positions, filed 2026-05-14. The largest single position is 1.7% of the whole book.

What changed since 2025-12-31

Opened (10)
New positions this quarter
Apple Inc$780.6M
Newmont Corp$180.9M
American Express Co$166.6M
Blackstone Inc$164.6M
Meta Platforms Inc$145.0M
Lumentum Hldgs Inc$142.5M
Vaneck Etf Trust$141.7M
Danaher Corp Del$128.7M
Synopsys Inc$120.6M
Morgan Stanley$110.9M
Exited (10)
Sold out completely
Procter And Gamble Co$427.9M
Ford Mtr Co$324.5M
Ge Vernova Inc$225.7M
Amazon Com Inc$205.6M
Schwab Charles Corp$180.9M
Palo Alto Networks Inc$167.3M
Exact Sciences Corp$161.6M
New Gold Inc Cda$138.3M
Starbucks Corp$112.2M
At&T Inc$111.5M
Added to (10)
Share count up 10%+
Nvidia Corporation$440.7M · +190%
Robinhood Mkts Inc$353.7M · +48.6%
Unitedhealth Group Inc$313.5M · +45.4%
Linde Plc$312.2M · +394.8%
Western Digital Corp$310.0M · +15.5%
Etsy Inc$298.0M · +11.1%
Broadcom Inc$245.7M · +89191%
New York Times Co Mtn Be$230.8M · +20.3%
Strategy Inc$230.8M · +122.6%
Adobe Inc$224.9M · +27.6%
Trimmed (10)
Share count down 10%+
Palantir Technologies Inc$1.02B · -20.6%
Micron Technology Inc$730.7M · -28.2%
Franco Nev Corp$548.2M · -10.5%
Sandisk Corp$508.0M · -33.9%
Carvana Co$377.6M · -14.6%
Intel Corp$326.5M · -25.2%
Gilead Sciences Inc$300.0M · -22.8%
Allison Transmission Hldgs I$264.6M · -13%
Vertiv Holdings Co$242.6M · -15.4%
Nu Hldgs Ltd$233.8M · -28.4%

Largest holdings

#CompanyValue% of bookShares
1United Therapeutics Corp Del$1.06B1.66%1,787,019
2Palantir Technologies Inc$1.02B1.60%6,985,926
3Apple Inc$780.6M1.22%3,075,638
4Kinross Gold Corp$779.7M1.22%25,546,413
5Micron Technology Inc$730.7M1.14%2,162,986
6Verisign Inc$699.9M1.09%2,818,151
7Exelixis Inc$588.8M0.92%13,726,993
8Franco Nev Corp$548.2M0.86%2,218,918
9Sandisk Corp$508.0M0.79%799,568
10Nvidia Corporation$440.7M0.69%2,526,948
11Chevron Corporation$417.0M0.65%2,015,396
12Roblox Corp$403.1M0.63%7,126,134
13Carvana Co$377.6M0.59%1,201,218
14Wayfair Inc$374.0M0.58%4,972,425
15Robinhood Mkts Inc$353.7M0.55%5,104,137
16Incyte Corp$343.7M0.54%3,651,532
17Argan Inc$332.7M0.52%610,899
18Intel Corp$326.5M0.51%7,399,394
19Neurocrine Biosciences Inc$318.7M0.50%2,418,897
20Unitedhealth Group Inc$313.5M0.49%1,158,428
21Sterling Infrastructure Inc$312.3M0.49%766,914
22Linde Plc$312.2M0.49%629,820
23Western Digital Corp$310.0M0.48%1,146,133
24Cboe Global Mkts Inc$309.3M0.48%1,100,506
25Gilead Sciences Inc$300.0M0.47%2,152,528
Before you copy any of this: 13F filings are disclosed up to 45 days after quarter end and cover US-listed long equity positions only — no shorts, bonds, or foreign holdings. This is a record of the past, not a signal, and not advice.

Other funds

berkshire hathawaybridgewaterpershing squarescion asset managementtiger globalappaloosaduquesne family office
Get the next autopsy

We test one strategy people swear by and publish whatever the data says — including when it says the strategy doesn't work. Free, no pitch.

Vorrik Research publishes tests of publicly discussed trading strategies using public market data and our own capital. It is factual reporting of what happened in historical and live tests — not investment advice, and not a recommendation to buy or sell anything. Past results never predict future results.